Navigation Links
Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
Date:9/25/2007

e of anti-tumor activity of this combination therapy. The trial is ongoing, as the most recently enrolled patients complete their initial six weekly treatments, all patients are monitored according to standard of care for tumor recurrence, and the patients enrolled at the MTD cohort continue maintenance dosing until the end of Year 2 of the study.

"We are pleased to have reached another important milestone in the development of Chemophase, which is proceeding along our expected timeline. We hope to announce interim data from this ongoing trial during the first half of next year," said Jonathan Lim, MD, Halozyme's President and CEO.

In the Chemophase Phase I trial, pharmacokinetic data were obtained from the plasma of five bladder cancer patients dosed intravesically with 20,000 units of Chemophase along with 40 mg of mitomycin. The observed plasma levels of mitomycin were less than 1/40th of the levels reported to be predictive of suppression of white blood cell production. The study was conducted at BCG Oncology in Phoenix, Arizona under the supervision of Donald L. Lamm, MD, the principal investigator.

The American Cancer Society estimates that there are approximately 67,000 new cases of bladder cancer diagnosed in the United States annually. At any given time, it is estimated that there are more than 500,000 bladder cancer patients in the U.S. According to Botteman et al., (PharmacoEconomics 2003), bladder cancer is the fifth most expensive cancer to treat. The initial treatment of this cancer is surgical removal of the tumor. Because of the high frequency of early recurrences of the tumor, patients are usually prescribed additional therapy to prevent or delay such recurrences. This additional therapy generally consists of immunotherapy or chemotherapy drugs instilled directly into the bladder.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products based on the extracellular
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015  Leaf Healthcare releases white paper on ... on the healthcare system . Institution-acquired ... quality healthcare. Research by the U.S. Department of ... and Quality shows that pressure ulcers cost the ... year. The condition is both excruciatingly painful for ...
(Date:7/28/2015)... BERN, Switzerland , July 28, 2015 /PRNewswire/ ... has accepted for review a Marketing Authorization Application ... linking recombinant coagulation factor IX with recombinant albumin ... episodes in people with Hemophilia B. Upon Swissmedic ... a long-acting treatment option with dosing intervals up ...
(Date:7/28/2015)... Cynosure, Inc. (Nasdaq: CYNO ), which ... procedures and precision surgical applications worldwide, today reported ... 30, 2015. "Our North American business ... increased 47 percent year-over-year and selling prices remained ... "While our international results reflected the economic slowdowns ...
Breaking Medicine Technology:Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13
(Date:7/28/2015)... Los Angeles, CA (PRWEB) , ... July 28, ... ... and engineer of patented products, announces Skimmer Helper, a household invention that cleans ... industry is worth $3 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique women’s ... take their healthy and mindful living practices to the next level, announced today an ... Living with Intent as keynote. Global Girls, an Orange County based non-profit that ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... 2015 , ... Darryl Worley’s Annual Tennessee River Run events ... of raising money for the Darryl Worley Foundation. Worley will host Wade Hayes, ... Saturday, Oct. 3. , This year’s concert will have a second stage showcasing ...
(Date:7/28/2015)... ... ... 2016, the number of smartphones worldwide will surpass 2 billion. This means that brands ... customer loyalty. However, capitalizing on this is not always obvious. Companies that do not, ... , The Open Mobile Summit 2015 is an influential gathering of mobile visionaries from ...
Breaking Medicine News(10 mins):Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3
... WASHINGTON, Aug. 30 The following was issued,today by ... and Executive Director, Active Minds, Inc. WHAT: Ms. ... and student advocacy, including depression and suicide Ms. ... and is,nationally recognized for her unique peer-to-peer approach in ...
... 30 Ronald Honberg,director of policy and legal affairs ... following statement on today,s Virginia Tech,Panel Report: "The ... problems,that exist not just in Virginia but throughout the ... a ,D, grade in,a national survey. The national average ...
... BD (Becton,Dickinson and Company) (NYSE: BDX ), a ... at the Bear Stearns 20th Annual,Healthcare Conference on Monday, ... live webcast of BD,s presentation can be accessed from ... be available for replay,through Monday, September 17, 2007. ...
... Aug. 30 Total U.S. investment in,health-related research grew ... than the 6.8% increase in U.S. health costs, according,to ... covered in,the August 31 issue of Science. The ... to,find new ways to treat, cure, and prevent disease ...
... younger children are getting their needed shots, federal surveys ... young U.S. children are getting their recommended vaccinations, but ... vaccines, U.S. health officials announced Thursday. , Last ... months had received their recommended vaccinations. While this is ...
... happen more frequently than thought, study says , THURSDAY, ... from one species inside another adds a twist to the ... Writing in the Aug. 30 issue of Science , ... code from another species may allow the host species to ...
Cached Medicine News:Health News:College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues 2Health News:Virginia Tech Report Has National Importance 2Health News:U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science 2Health News:U.S. Teens Fall Short on Vaccine Coverage 2Health News:U.S. Teens Fall Short on Vaccine Coverage 3Health News:One Species' Genome Found Within Another 2
... Clini-RF is a new type of freezer designed ... It has a rapid freezer tank which can ... immersion of the specimens. ,The Clini-RF eliminates the ... carbon dioxide and liquid nitrogen. In order to ...
... series Freezing Stages fit easily onto most microtomes. ... and need only the AC supply and a ... Freezing starts immediately and can be maintained indefinitely. ... cutting temperatures can be set for different kinds ...
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Inquire...
Medicine Products: